Viewing Study NCT05293912


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2025-12-26 @ 10:17 PM
Study NCT ID: NCT05293912
Status: TERMINATED
Last Update Posted: 2025-03-18
First Post: 2022-03-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.
Sponsor: Hangzhou Sumgen Biotech Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module